FDA Adverse Event Injury Summary report: N

ENDURON 10D 54OD X 28ID

MDR report key: 2243317 · Received September 12, 2011

Report

Report Number
1818910-2011-17657
Event Type
Injury
Date Received
September 12, 2011
Report Date
September 10, 2011
Manufacturer
DEPUY IRELAND
Product Code
KWY
PMA / PMN Number
K940743
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EXAMINATION OF THE REPORTED DEVICES WAS NOT ABLE TO CONCLUSIVELY CONFIRM THE REPORTED EVENT. A REVIEW OF THE DEVICE HISTORY RECORDS BY DEPUY INTERNATIONAL FINDS NO RELATED MANUFACTURING DEVIATIONS OR ANOMALIES THAT WOULD HAVE CONTRIBUTED TO THE EVENT. A SEARCH OF THE COMPLAINTS DATABASES FINDS NO OTHER REPORTS AGAINST THE PRODUCT AND LOT CODE COMBINATIONS SINCE THEIR RELEASE TO DISTRIBUTION. THE INVESTIGATION CAN DRAW NO CONCLUSIONS WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO DETERMINE ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION HAS NOT BEEN INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

THE INVESTIGATION IDENTIFIED THAT IN THE ABSENCE OF COMPLAINT PRODUCTS AND PATIENT X-RAYS, INSUFFICIENT INFORMATION HAS BEEN PROVIDED TO COMPLETE A FULL INVESTIGATION.THE COMPLAINT SHALL BE CLOSED WITH AN INDETERMINED CONCLUSION; IT SHALL BE ENTERED ONTO THE COMPLAINTS DATABASE AND MONITORED THROUGH TREND ANALYSIS. SHOULD FURTHER INFORMATION BE RECEIVED, THEN THE COMPLAINT SHALL BE INVESTIGATED FURTHER.

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Description of Event or Problem · 1

THE PATIENT WILL BE REVISED DUE TO PSEUDOTUMOR TUMOR ON (B)(6) 2011.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDURON 10D 54OD X 28ID HIP LINER KWY DEPUY IRELAND 1893517

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention